Changes in inflammatory and clinical parameters and in bronchial hyperreactivity in asthmatic children sensitized to house dust mites following sublingual immunotherapy

Journal of Investigational Allergology and Clinical Immunology

Volumn 12, Issue 1, 2002, Pages 52-59

  Silvestri, Michela ^a   Spallarossa, Daniela ^a   Battistini, Elena ^a   Sabatini, Federica ^a   Pecora, Silvia ^a   Parmiani, Silvano ^a   Rossi, Giovanni A ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Allergic asthma; Bronchial hyperreactivity; House dust mites; Intercellular adhesion molecule 1; Sublingual immunotherapy

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CHROMONE DERIVATIVE; HOUSE DUST ALLERGEN; INTERCELLULAR ADHESION MOLECULE 1; METHACHOLINE;

ALLERGIC ASTHMA; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DOWN REGULATION; EOSINOPHILIA; EPITHELIUM CELL; FEMALE; FLUORESCENCE; HUMAN; IMMUNOTHERAPY; INFLAMMATION; LUNG FUNCTION TEST; MALE; PROTEIN EXPRESSION; RHINOCONJUNCTIVITIS; SCHOOL CHILD; SCORING SYSTEM; SENSITIZATION; SIDE EFFECT; SYMPTOM;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; CONJUNCTIVITIS, ALLERGIC; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DUST; FEMALE; HOUSING; HUMANS; IMMUNOTHERAPY; MALE; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 0036251106     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Asthma and inflammation
2. Mediators and cytokine mechanisms in asthma
3. Is childhood asthma an inflammatory disease?
4. Bronchial asthma in infancy and childhood
5. WHO Position Paper. Allergen immunotherapy: Therapeutical vaccines for allergic diseases
6. A controlled dose-response study of immunotherapy with standardized partially purified extract of house dust mite: Clinical efficacy and side effects
7. Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma
8. New routes and formulations for allergen-specific immunotherapy
9. EAACI Immunotherapy position paper
10. Local Immunotherapy. Position Paper by the Working Group on Local Immunotherapy of the EAACI Subcommittee and the ESPACI Immunotherapy Subcommittee
11. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mites. A double blind study
12. Sublingual immunotherapy in Parietaria pollen induced rhinitis: A double blind study
13. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract
14. Clinical efficacy of sublingual-swallow immunotherapy: A double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis
15. Safety and efficacy of immunotherapy with grass allergen extract. A double-blind study
16. Sublingual versus injective immunotherapy in grass pollen allergenic patients: A double blind (double dummy) study
17. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy
18. Double-blind placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in peditaric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization
19. Sublingual-swallow immunotherapy (SLIT2) in patients with asthma due to house-dust mites: A double-blind, placebo-controlled study
20. House dust mite sublingual-swallow immunotherapy (SLIT2) in perennial rhinitis: A double blind, placebo controlled study
21. Randomized controlled trial of allergoig immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis
22. Frequency and specific sensitization to inhalant allergens within nuclear families of children with asthma and/or rhinitis
23. Clinical and immunological effects of a rush sublingual immunotherapy to Parietaria species: Double-blind, placebo-controlled trial
24. Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild-intermittent asthma
25. Modulation of HLA-DR antigen and ICAM-1 molecule expression on airway epithelial cells by sodium nedocromil
26. Inhibition of transepithelial migration and downregulation of adhesion molecule expression on eosinophils and airway epithelial cells induced by budesonide
27. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mites extract (D. pt.) in children
28. Clinical and immunological effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: A double blind, placebo controlled study
29. Follow-up of asthma from childhood to adulthood: Influence of potential childhood risk factors on the outcome of pulmonary function and bronchial hyperresponsiveness
30. Bronchial responsiveness to histamine and methacholine in asthma: Measurement and clinical significance
31. Prognosis of asthma from childhood to adulthood
32. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness
33. Adhesion receptors of the immune system
34. Intracellular adhesion molecule - 1 (ICAM-1) and endothelial leukocyte adhesion molecule - 1 (ELAM-1) expression in the bronchial mucosa of normal and asthmatic subjects
35. Induction of ICAM - 1 expression on human airway epithelial cells by inflammatory cytokines: Effects on neutrophil-epithelial cells adhesion
36. Molecular determinants of neutrophil adhesion
37. +T cells from allergic individuals
38. Increases in interleukin-12 messenger RNA+ cells accompany inhibition of allergen induced late skin responses following successful grass pollen immunotherapy
39. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity
40. Estudio multicentrico de farmacovigilancia de immunoterapia sublingual en pacientes alérgicos